Anti-MDA5 Antibody Spectrum in Western World

Dermatomyositis with Rapidly Progressive Interstitial Lung Disease Treated with Rituximab: A Report of 3 Cases in Japan

(2017) Kenichiro Tokunaga et al.   INTERNAL MEDICINE

Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis

(2017) Yasuhiro Shimojima et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis

(2017) Siamak Moghadam-Kia et al.   JOURNAL OF RHEUMATOLOGY

Dermatomyositis With or Without Anti-Melanoma Differentiation-Associated Gene 5 Antibodies

(2016) Yves Allenbach et al.   AMERICAN JOURNAL OF PATHOLOGY

Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis

(2016) Siamak Moghadam-Kia et al.   ARTHRITIS CARE & RESEARCH

Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies

(2016) Shinji Sato et al.   PLoS One

Diagnosis and treatment of clinically amyopathic dermatomyositis (CADM): a case series and literature review

(2015) Bornstein Gil et al.   CLINICAL RHEUMATOLOGY

A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment

(2015) Yamaguchi Koichi et al.   Modern Rheumatology

Diffuse alveolar damage in patients with dermatomyositis: a six-case series

(2014) Yuko Matsuki et al.   Modern Rheumatology

Prognostic Factors for Myositis-Associated Interstitial Lung Disease

(2014) Tomoyuki Fujisawa et al.   PLoS One

Response of Mucocutaneous Lesions to Rituximab in a Case of Melanoma Differentiation Antigen 5-Related Dermatomyositis

(2013) Aurélie Clottu et al.   DERMATOLOGY

Utility of Anti-Melanoma Differentiation-Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta-Analysis

(2013) Zhiyong Chen et al.   ARTHRITIS CARE & RESEARCH

Anti-Melanoma Differentiation-Associated Protein 5-Associated Dermatomyositis: Expanding the Clinical Spectrum

(2013) John C. Hall et al.   ARTHRITIS CARE & RESEARCH

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

(2012) T. Gono et al.   RHEUMATOLOGY

Clinical Correlations With Dermatomyositis-Specific Autoantibodies in Adult Japanese Patients With Dermatomyositis

(2011) Yasuhito Hamaguchi et al.   ARCHIVES OF DERMATOLOGY

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

(2010) T. Gono et al.   RHEUMATOLOGY

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

(2009) Ran Nakashima et al.   RHEUMATOLOGY